Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02POA
|
|||
| Former ID |
DNC007757
|
|||
| Drug Name |
5-(1,1-dimethyl-heptyl)-2-pyridin-3-yl-phenol
|
|||
| Synonyms |
CHEMBL234207; 5-(1,1-dimethyl-heptyl)-2-pyridin-3-yl-phenol; SCHEMBL4888568; OYBDWAVFBKZYIO-UHFFFAOYSA-N; BDBM50213139; 5-(1,1-Dimethylheptyl)-2-pyridin-3-yl phenol
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H27NO
|
|||
| Canonical SMILES |
CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CN=CC=C2)O
|
|||
| InChI |
1S/C20H27NO/c1-4-5-6-7-12-20(2,3)17-10-11-18(19(22)14-17)16-9-8-13-21-15-16/h8-11,13-15,22H,4-7,12H2,1-3H3
|
|||
| InChIKey |
OYBDWAVFBKZYIO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 1 (CB1) | Target Info | Inhibitor | [1] |
| Cannabinoid receptor 2 (CB2) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Rap1 signaling pathway | ||||
| Retrograde endocannabinoid signaling | ||||
| Panther Pathway | Endogenous cannabinoid signaling | |||
| Pathway Interaction Database | N-cadherin signaling events | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| BDNF signaling pathway | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Biaryl cannabinoid mimetics--synthesis and structure-activity relationship. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3652-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.